In 2024, the U.S. healthcare industry spent $6.1 billion on Pfizer’s COVID-19 therapy Paxlovid, a 6,922.8% increase from 2023 expenditure data, according to a recent study. The research, published ...

Numerous companies are producing automated pharmacy systems that upgrade pharmaceutical workplaces every day. Learning which ...

As we stride further into 2025, the pharmacy industry faces a landscape teeming with challenges and opportunities. From tackling drug ...